Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
immunodeficiency Agenda & Minutes Germany Measles Mumps Rubella Pertussis Varicella
Download:
Agenda & Minutes Germany Influenza Pertussis Measles Mumps Rubella Japanese encephalitis Varicella
Download:
NITAG recommendation Recommendation Chile Varicella
Download:
Recommendation Belgium Varicella
Download:
Economic aspects All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Hepatitis B Varicella
Economic aspects All age groups Germany Mumps Measles Pertussis Varicella
Zika
Download:
Varicella
Varicella
Download: